Literature DB >> 21605678

Purification and characterization of tagless recombinant human elongation factor 2 kinase (eEF-2K) expressed in Escherichia coli.

Olga Abramczyk1, Clint D J Tavares, Ashwini K Devkota, Alexey G Ryazanov, Benjamin E Turk, Austen F Riggs, Bulent Ozpolat, Kevin N Dalby.   

Abstract

The eukaryotic elongation factor 2 kinase (eEF-2K) modulates the rate of protein synthesis by impeding the elongation phase of translation by inactivating the eukaryotic elongation factor 2 (eEF-2) via phosphorylation. eEF-2K is known to be activated by calcium and calmodulin, whereas the mTOR and MAPK pathways are suggested to negatively regulate kinase activity. Despite its pivotal role in translation regulation and potential role in tumor survival, the structure, function, and regulation of eEF-2K have not been described in detail. This deficiency may result from the difficulty of obtaining the recombinant kinase in a form suitable for biochemical analysis. Here we report the purification and characterization of recombinant human eEF-2K expressed in the Escherichia coli strain Rosetta-gami 2(DE3). Successive chromatography steps utilizing Ni-NTA affinity, anion-exchange, and gel filtration columns accomplished purification. Cleavage of the thioredoxin-His(6)-tag from the N-terminus of the expressed kinase with TEV protease yielded 9 mg of recombinant (G-D-I)-eEF-2K per liter of culture. Light scattering shows that eEF-2K is a monomer of ∼85 kDa. In vitro kinetic analysis confirmed that recombinant human eEF-2K is able to phosphorylate wheat germ eEF-2 with kinetic parameters comparable to the mammalian enzyme.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21605678      PMCID: PMC3389548          DOI: 10.1016/j.pep.2011.05.005

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  45 in total

Review 1.  Signal transduction pathways that regulate eukaryotic protein synthesis.

Authors:  R E Rhoads
Journal:  J Biol Chem       Date:  1999-10-22       Impact factor: 5.157

2.  Alpha-kinases: a new class of protein kinases with a novel catalytic domain.

Authors:  A G Ryazanov; K S Pavur; M V Dorovkov
Journal:  Curr Biol       Date:  1999-01-28       Impact factor: 10.834

3.  Farnesyltransferase inhibitor SCH66336 induces rapid phosphorylation of eukaryotic translation elongation factor 2 in head and neck squamous cell carcinoma cells.

Authors:  Hening Ren; Shyh-Kuan Tai; Fadlo Khuri; Zuming Chu; Li Mao
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

4.  Identification of a new class of protein kinases represented by eukaryotic elongation factor-2 kinase.

Authors:  A G Ryazanov; M D Ward; C E Mendola; K S Pavur; M V Dorovkov; M Wiedmann; H Erdjument-Bromage; P Tempst; T G Parmer; C R Prostko; F J Germino; W N Hait
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

5.  Cyclic AMP-dependent protein kinase phosphorylates rabbit reticulocyte elongation factor-2 kinase and induces calcium-independent activity.

Authors:  N T Redpath; C G Proud
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

6.  Elongation factor-2 kinase: its role in protein synthesis and autophagy.

Authors:  William N Hait; Hao Wu; Shenkan Jin; Jin-Ming Yang
Journal:  Autophagy       Date:  2006-10-03       Impact factor: 16.016

7.  Analysis of the domain structure of elongation factor-2 kinase by mutagenesis.

Authors:  T A Diggle; C K Seehra; S Hase; N T Redpath
Journal:  FEBS Lett       Date:  1999-08-27       Impact factor: 4.124

8.  Role of calmodulin-dependent phosphorylation of elongation factor 2 in the proliferation of rat glial cells.

Authors:  D M Bagaglio; W N Hait
Journal:  Cell Growth Differ       Date:  1994-12

9.  Elongation factor-2 kinase regulates autophagy in human glioblastoma cells.

Authors:  Hao Wu; Jin-Ming Yang; Shengkan Jin; Haiyan Zhang; William N Hait
Journal:  Cancer Res       Date:  2006-03-15       Impact factor: 12.701

10.  Purification and characterization of calmodulin-dependent protein kinase III from rabbit reticulocytes and rat pancreas.

Authors:  K Mitsui; M Brady; H C Palfrey; A C Nairn
Journal:  J Biol Chem       Date:  1993-06-25       Impact factor: 5.157

View more
  14 in total

1.  Solution Structure of the Carboxy-Terminal Tandem Repeat Domain of Eukaryotic Elongation Factor 2 Kinase and Its Role in Substrate Recognition.

Authors:  Andrea Piserchio; Nathan Will; David H Giles; Fatlum Hajredini; Kevin N Dalby; Ranajeet Ghose
Journal:  J Mol Biol       Date:  2019-05-18       Impact factor: 5.469

2.  Structural Dynamics of the Activation of Elongation Factor 2 Kinase by Ca2+-Calmodulin.

Authors:  Nathan Will; Kwangwoon Lee; Fatlum Hajredini; David H Giles; Rinat R Abzalimov; Michael Clarkson; Kevin N Dalby; Ranajeet Ghose
Journal:  J Mol Biol       Date:  2018-05-22       Impact factor: 5.469

3.  Arrestin-3-Dependent Activation of c-Jun N-Terminal Kinases (JNKs).

Authors:  Xuanzhi Zhan; Seunghyi Kook; Tamer S Kaoud; Kevin N Dalby; Eugenia V Gurevich; Vsevolod V Gurevich
Journal:  Curr Protoc Pharmacol       Date:  2015-03-02

4.  Investigating the kinetic mechanism of inhibition of elongation factor 2 kinase by NH125: evidence of a common in vitro artifact.

Authors:  Ashwini K Devkota; Clint D J Tavares; Mangalika Warthaka; Olga Abramczyk; Kyle D Marshall; Tamer S Kaoud; Kivanc Gorgulu; Bulent Ozpolat; Kevin N Dalby
Journal:  Biochemistry       Date:  2012-03-05       Impact factor: 3.162

5.  Calcium/calmodulin stimulates the autophosphorylation of elongation factor 2 kinase on Thr-348 and Ser-500 to regulate its activity and calcium dependence.

Authors:  Clint D J Tavares; John P O'Brien; Olga Abramczyk; Ashwini K Devkota; Kevin S Shores; Scarlett B Ferguson; Tamer S Kaoud; Mangalika Warthaka; Kyle D Marshall; Karin M Keller; Yan Zhang; Jennifer S Brodbelt; Bulent Ozpolat; Kevin N Dalby
Journal:  Biochemistry       Date:  2012-03-06       Impact factor: 3.162

6.  Structure of the C-Terminal Helical Repeat Domain of Eukaryotic Elongation Factor 2 Kinase.

Authors:  Nathan Will; Andrea Piserchio; Isaac Snyder; Scarlet B Ferguson; David H Giles; Kevin N Dalby; Ranajeet Ghose
Journal:  Biochemistry       Date:  2016-09-14       Impact factor: 3.162

7.  The molecular mechanism of eukaryotic elongation factor 2 kinase activation.

Authors:  Clint D J Tavares; Scarlett B Ferguson; David H Giles; Qiantao Wang; Rebecca M Wellmann; John P O'Brien; Mangalika Warthaka; Jennifer S Brodbelt; Pengyu Ren; Kevin N Dalby
Journal:  J Biol Chem       Date:  2014-07-10       Impact factor: 5.157

8.  Signal Integration at Elongation Factor 2 Kinase: THE ROLES OF CALCIUM, CALMODULIN, AND SER-500 PHOSPHORYLATION.

Authors:  Clint D J Tavares; David H Giles; Gabriel Stancu; Catrina A Chitjian; Scarlett B Ferguson; Rebecca M Wellmann; Tamer S Kaoud; Ranajeet Ghose; Kevin N Dalby
Journal:  J Biol Chem       Date:  2016-12-12       Impact factor: 5.157

9.  Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth In Vivo.

Authors:  Ferah Comert Onder; Nermin Kahraman; Esen Bellur Atici; Ali Cagir; Hakan Kandemir; Gizem Tatar; Tugba Taskin Tok; Goknur Kara; Bekir Karliga; Serdar Durdagi; Mehmet Ay; Bulent Ozpolat
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-30

10.  Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancer.

Authors:  Ibrahim Tekedereli; S Neslihan Alpay; Clint D J Tavares; Zehra E Cobanoglu; Tamer S Kaoud; Ibrahim Sahin; Anil K Sood; Gabriel Lopez-Berestein; Kevin N Dalby; Bulent Ozpolat
Journal:  PLoS One       Date:  2012-07-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.